Novel Process For Preparation Of Bosentan
AssigneeMegafine Pharma(P) Ltd.
InventorsVijayavitthal Thippannachar Mathad, Navnath Chintaman Niphade, Kunal Madhav Jagtap, Chandrashekar Trimbak Gaikwad
Life of this patent
Estimating the term…
Loading patent…
AssigneeMegafine Pharma(P) Ltd.
InventorsVijayavitthal Thippannachar Mathad, Navnath Chintaman Niphade, Kunal Madhav Jagtap, Chandrashekar Trimbak Gaikwad
Estimating the term…
A novel ammonium salt of Bosentan of formula (VIII); has been disclosed. The salt may be either crystalline or amorphous or mixture of Crystalline and amorphous form. A novel single pot process for the preparations of ammonium salt of Bosentan has been disclosed. The process comprises reacting the 4,6-dichloro-5-(2-methoxyphenoxy)-2,2′-bipyrimidine with 4-tert-butylbenzenesulfonamide in the presence of solvent and a base; adding ethylene glycol to the reaction mass and isolating the ammonium salt of Bosentan. The ammonium salt of Bosentan is converted into Bosentan and further into Bosentan Monohydrate which are substantially free from dimer impurity and 6-hydroxy impurity.
An ammonium salt of Bosentan of formula (VIII);
(canceled)
An amorphous form of ammonium salt of Bosentan of formula (VIII), comprising an XRD pattern as shown in FIG. 2.
A single pot process for the preparations of an ammonium salt of Bosentan of the formula (VIII), the process comprising:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A process for the preparation of an amorphous form of an ammonium salt of Bosentan, said process comprising providing a solution of crystalline or a mixture of crystalline and the amorphous form of the ammonium salt of Bosentan in a solvent, removing the solvent to form a solid residue and isolating the solid residue to obtain the amorphous form of the ammonium salt of Bosentan.
(canceled)
A process for the preparation of a Bosentan of the formula (I), the process comprising hydrolyzing the ammonium salt of the Bosentan of the formula (VIII) by adding water to the ammonium salt, followed by adjusting the pH of the reaction mass to a value in the range of 1 to 6 using acid, extracting the Bosentan of the formula (I) from the hydrolyzed reaction mass using a solvent selected from a halogenated hydrocarbon comprising dichloromethane, dichloroethane, or chloroform;
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A process for the preparation of a Bosentan monohydrate of the formula (II), the process comprising dissolving the Bosentan of the formula (I) in a solvent;
The process as claimed in 43, wherein the solvent used in the preparation of the Bosentan monohydrate of the formula (II) is an alcohol comprising methanol, ethanol, propanol, or butanol.
(canceled)
(canceled)
Dependencies are inferred from the claim text.